A detailed history of Saybrook Capital transactions in Johnson & Johnson stock. As of the latest transaction made, Saybrook Capital holds 24,292 shares of JNJ stock, worth $3.78 Million. This represents 1.14% of its overall portfolio holdings.

Number of Shares
24,292
Previous 44,486 45.39%
Holding current value
$3.78 Million
Previous $6.5 Million 39.46%
% of portfolio
1.14%
Previous 1.84%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$145.48 - $167.38 $2.94 Million - $3.38 Million
-20,194 Reduced 45.39%
24,292 $3.94 Million
Q2 2024

Aug 07, 2024

SELL
$144.38 - $157.78 $980,051 - $1.07 Million
-6,788 Reduced 13.24%
44,486 $6.5 Million
Q1 2024

May 03, 2024

SELL
$155.22 - $162.74 $283,431 - $297,163
-1,826 Reduced 3.44%
51,274 $8.11 Million
Q4 2023

Jan 30, 2024

SELL
$145.6 - $158.88 $1.42 Million - $1.55 Million
-9,785 Reduced 15.56%
53,100 $8.32 Million
Q3 2023

Nov 03, 2023

SELL
$155.75 - $174.48 $1.9 Million - $2.13 Million
-12,214 Reduced 16.26%
62,885 $9.79 Million
Q2 2023

Aug 02, 2023

SELL
$154.35 - $166.11 $69,457 - $74,749
-450 Reduced 0.6%
75,099 $12.4 Million
Q1 2023

Apr 28, 2023

SELL
$151.05 - $180.26 $33,231 - $39,657
-220 Reduced 0.29%
75,549 $11.7 Million
Q4 2022

Feb 08, 2023

SELL
$160.2 - $179.79 $668,354 - $750,083
-4,172 Reduced 5.22%
75,769 $13.4 Million
Q3 2022

Nov 04, 2022

SELL
$161.33 - $179.52 $154,070 - $171,441
-955 Reduced 1.18%
79,941 $13.1 Million
Q2 2022

Aug 03, 2022

SELL
$168.19 - $186.01 $16,819 - $18,601
-100 Reduced 0.12%
80,896 $14.4 Million
Q1 2022

May 05, 2022

BUY
$158.14 - $179.59 $6,325 - $7,183
40 Added 0.05%
80,996 $14.4 Million
Q4 2021

Jan 28, 2022

BUY
$155.93 - $173.01 $228,437 - $253,459
1,465 Added 1.84%
80,956 $13.8 Million
Q3 2021

Nov 02, 2021

SELL
$161.5 - $179.47 $67,830 - $75,377
-420 Reduced 0.53%
79,491 $12.8 Million
Q2 2021

Jul 20, 2021

BUY
$159.48 - $171.07 $348,942 - $374,301
2,188 Added 2.82%
79,911 $13.2 Million
Q1 2021

May 10, 2021

BUY
$153.07 - $170.48 $15,307 - $17,048
100 Added 0.13%
77,723 $12.8 Million
Q4 2020

Feb 12, 2021

BUY
$137.11 - $157.38 $534,180 - $613,152
3,896 Added 5.28%
77,623 $12.2 Million
Q3 2020

Nov 10, 2020

BUY
$140.38 - $153.83 $161,437 - $176,904
1,150 Added 1.58%
73,727 $11 Million
Q2 2020

Aug 05, 2020

BUY
$128.81 - $155.51 $3,220 - $3,887
25 Added 0.03%
72,577 $10.2 Million
Q1 2020

May 04, 2020

BUY
$111.14 - $153.99 $2.15 Million - $2.99 Million
19,385 Added 36.46%
72,552 $9.51 Million
Q1 2020

Apr 27, 2020

SELL
$111.14 - $153.99 $1.92 Million - $2.66 Million
-17,260 Reduced 24.51%
53,167 $5.75 Million
Q4 2019

Feb 05, 2020

SELL
$127.5 - $146.44 $446,887 - $513,272
-3,505 Reduced 4.74%
70,427 $10.3 Million
Q3 2019

Nov 06, 2019

BUY
$126.95 - $142.14 $270,403 - $302,758
2,130 Added 2.97%
73,932 $9.57 Million
Q2 2019

Aug 09, 2019

SELL
$131.15 - $144.24 $72,788 - $80,053
-555 Reduced 0.77%
71,802 $10 Million
Q1 2019

May 10, 2019

SELL
$125.72 - $139.79 $230,067 - $255,815
-1,830 Reduced 2.47%
72,357 $10.1 Million
Q4 2018

Feb 11, 2019

SELL
$122.84 - $147.84 $73,704 - $88,704
-600 Reduced 0.8%
74,187 $9.57 Million
Q3 2018

Nov 13, 2018

BUY
$121.58 - $142.88 $57,750 - $67,868
475 Added 0.64%
74,787 $10.3 Million
Q2 2018

Aug 13, 2018

BUY
$119.4 - $131.76 $839,979 - $926,931
7,035 Added 10.46%
74,312 $9.02 Million
Q1 2018

May 14, 2018

BUY
$125.1 - $148.14 $975,154 - $1.15 Million
7,795 Added 13.1%
67,277 $8.62 Million
Q4 2017

Feb 14, 2018

BUY
$131.22 - $143.62 $276,874 - $303,038
2,110 Added 3.68%
59,482 $8.31 Million
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $258,940 - $270,760
2,000 Added 3.61%
57,372 $7.46 Million
Q2 2017

Aug 14, 2017

BUY
N/A
55,372
55,372 $7.33 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $407B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Saybrook Capital Portfolio

Follow Saybrook Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saybrook Capital , based on Form 13F filings with the SEC.

News

Stay updated on Saybrook Capital with notifications on news.